Coya Therapeutics, Inc. COYA
- COYA 302 — Amyotrophic Lateral Sclerosis Phase 2
- COYA 301 Preclinical
- COYA 302 — Frontotemporal Dementia Phase 1
- COYA 303 Preclinical
IL-2 (3 companies · 8 programs)
Companies with an active program directed at IL-2.
Medicenna Therapeutics Corp. MDNAF
- MDNA11 — Solid Tumors Phase 1
- MDNA11 — Melanoma Phase 1
- MDNA113 Preclinical
Cue Biopharma, Inc. CUE
- CUE-401 Preclinical